Table 2 FM score at baseline (W0) and W24 of PKAN patients (P1, P2 and P3)
From: A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
ID | W0 | W24 | ΔW24-W0 |
|---|---|---|---|
P1 | 23.0 | 15.0 | −8.0 |
P2 | 98.0 | 74.0 | −24.0 |
P3 | 56.0 | 56.0 | 0.0 |
From: A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
ID | W0 | W24 | ΔW24-W0 |
|---|---|---|---|
P1 | 23.0 | 15.0 | −8.0 |
P2 | 98.0 | 74.0 | −24.0 |
P3 | 56.0 | 56.0 | 0.0 |
Orphanet Journal of Rare Diseases